Health / Medical Topics |
Sargramostim Plasmid DNA Hepatocellular Carcinoma Vaccine Adjuvant
A vaccine adjuvant consisting of a plasmid DNA encoding sargramostim (granulocyte-macrophage colony-stimulating factor). Upon administration, expressed sargramostim may stimulate a cytotoxic T cell response enhancing the host immune response to a concomitantly administered hepatocellular carcinoma vaccine. (NCI Thesaurus)
YOU MAY ALSO LIKE
A substance that helps make more white blood cells, especially granulocytes, macrophages, and cells that become platelets. It is a cytokine that…
A methylglyoxal-bis(guanylhydrazone) (MGBG) derivative with potential antineoplastic and antiviral properties. Sardomozide selectively binds to and inhibits S-adenosylmethionine decarboxylase (SAMDC), an enzyme essential…
Sarcospan (1304 aa, 144 kD) is a cell adhesion process protein that is encoded by the human SSPN gene and has roles…
A substance being studied in the treatment of cancer. It is a type of alkylating agent. Also called sarCNU.
Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (1042 aa, ~115 kDa) is encoded by the human ATP2A2 gene. This protein plays a role in…
The endoplasmic reticulum of striated muscle, specialised for the sequestration of calcium ions that are released upon receipt of a signal relayed…